PYGL (NM_002863) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC210683L4V
- LentiORF®
Lenti ORF particles, PYGL (mGFP-tagged) - Human phosphorylase, glycogen, liver (PYGL), transcript variant 1, 200ul, >10^7 TU/mL
Product Images
Other products for "PYGL"
Specifications
Product Data | |
Type | Human Tagged ORF Clone Lentiviral Particle |
Tag | mGFP |
Symbol | PYGL |
Synonyms | GSD6 |
Mammalian Cell Selection | Puromycin |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | NM_002863 |
ORF Size | 2541 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC210683).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_002863.3, NP_002854.3 |
RefSeq Size | 2859 bp |
RefSeq ORF | 2544 bp |
Locus ID | 5836 |
Cytogenetics | 14q22.1 |
Domains | phosphorylase |
Protein Families | Druggable Genome |
Protein Pathways | Insulin signaling pathway, Starch and sucrose metabolism |
MW | 97.1 kDa |
Gene Summary | 'This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]' |
Documents
Product Manuals |
FAQs |
Resources
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.